Senior insider sale
Chief Commercial Officer at CYMABAY THERAPEUTICS, INC. — senior position signals high conviction
$12.15M
511.09K shares
STUART LEWIS J plans to sell 511.09K shares of CYMABAY THERAPEUTICS, INC. valued at approximately $12.15M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
STOCK OPTION EXERCISE
COMPENSATION
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/6/2024 | STOCK OPTION EXERCISE COMPENSATION | 30.62K | — |
| Total | 30.62K | ||
Completed
Units to sell
500.00
Market value
$11.9K
Units to sell
31.64K
Market value
$778.4K
Units to sell
50K
Market value
$1.21M
Units to sell
60.75K
Market value
$1.43M
Units to sell
40.16K
Market value
$951.7K
Units to sell
50K
Market value
$1.19M
Units to sell
27.97K
Market value
$669.2K
Units to sell
50K
Market value
$1.20M
Units to sell
50K
Market value
$1.18M
Units to sell
50K
Market value
$1.19M
Units to sell
50K
Market value
$1.16M
Units to sell
19.45K
Market value
$452.3K
Planned — Approximate Date
Units to sell
30.62K
Market value
$733.3K
Units
511.09K
Value
$12.15M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/29/2024 | 500.00 | $11.9K | — | Completed |
1/22/2024 | 31.64K | $778.4K | — | Completed |
1/19/2024 | 50K | $1.21M | — | Completed |
1/18/2024 | 60.75K | $1.43M | — | Completed |
1/17/2024 | 40.16K | $951.7K | — | Completed |
1/16/2024 | 50K | $1.19M | — | Completed |
1/12/2024 | 27.97K | $669.2K | — | Completed |
1/11/2024 | 50K | $1.20M | — | Completed |
1/10/2024 | 50K | $1.18M | — | Completed |
1/9/2024 | 50K | $1.19M | — | Completed |
1/8/2024 | 50K | $1.16M | — | Completed |
1/4/2024 | 19.45K | $452.3K | — | Completed |
| Planned — Approximate Date | ||||
2/6/2024 | 30.62K | $733.3K | NASDAQ | Planned |
| Total | 511.09K | $12.15M | ||